Get the Stockscreener App
2.12
0.00%
0.00
After Hours:
2.10
-0.02
-0.94%
Sab Biotherapeutics Inc stock is traded at $2.12, with a volume of 59,844.
It is up +0.00% in the last 24 hours and down -1.85% over the past month.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
See More
Previous Close:
$2.12
Open:
$2.07
24h Volume:
59,844
Relative Volume:
0.04
Market Cap:
$22.07M
Revenue:
-
Net Income/Loss:
$-45.57M
P/E Ratio:
-0.3365
EPS:
-6.3
Net Cash Flow:
$-38.56M
1W Performance:
-6.61%
1M Performance:
-1.85%
6M Performance:
+32.50%
1Y Performance:
-23.33%
1-Day Range:
$2.07
$2.1655
1-Week Range:
$2.07
$2.24
52-Week Range:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Name
Sab Biotherapeutics Inc
Sector
Industry
Phone
305-845-2813
Address
777 W 41ST ST, MIAMI BEACH
Compare SABS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
2.12 | 22.18M | 0 | -45.57M | -38.56M | -6.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Resumed | H.C. Wainwright | Buy |
| Oct-09-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Nov-05-21 | Initiated | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Stock (SABS) Latest News
Is this a good reentry point in SAB Biotherapeutics Inc. Equity WarrantShort Setup & Accurate Entry/Exit Alerts - Newser
Why SAB Biotherapeutics Inc. Equity Warrant is moving todayTake Profit & Real-Time Chart Pattern Alerts - Newser
SAB Biotherapeutics Inc. stock daily chart insightsRate Hike & Weekly Watchlist of Top Performers - Newser
How to escape a deep drawdown in SAB Biotherapeutics Inc.Earnings Risk Summary & Expert Curated Trade Setup Alerts - Newser
SAB Biotherapeutics Inc. Equity Warrant stock trend outlook and recovery pathSell Signal & Real-Time Volume Trigger Notifications - Newser
How high can SAB Biotherapeutics Inc. Equity Warrant stock goTrade Volume Report & High Conviction Trade Alerts - Newser
Volatility clustering patterns for SAB Biotherapeutics Inc.July 2025 Opening Moves & Consistent Income Trade Ideas - Newser
Is SAB Biotherapeutics Inc. forming a bottoming base2025 EndofYear Setup & AI Enhanced Execution Alerts - Newser
Long term hold vs stop loss in SAB Biotherapeutics Inc.July 2025 Sentiment & Fast Gain Swing Trade Alerts - Newser
Pattern recognition hints at SAB Biotherapeutics Inc. upsideMarket Movers & Weekly Consistent Profit Watchlists - Newser
What indicators show strength in SAB Biotherapeutics Inc. Equity Warrant2025 Market WrapUp & Safe Capital Growth Tips - Newser
How to integrate SAB Biotherapeutics Inc. Equity Warrant into portfolio analysis toolsTrade Entry Report & Verified Swing Trading Watchlist - Newser
Automated trading signals detected on SAB Biotherapeutics Inc.Trade Ideas & AI Optimized Trading Strategy Guides - Newser
Quantitative breakdown of SAB Biotherapeutics Inc. recent move2025 Growth vs Value & Fast Gain Stock Trading Tips - Newser
SAB Biotherapeutics Inc. Equity Warrant’s volatility index tracking explained2025 Buyback Activity & Expert Approved Trade Ideas - Newser
Technical analysis overview for SAB Biotherapeutics Inc. Equity Warrant stockJuly 2025 Levels & Accurate Intraday Trading Signals - Newser
Using economic indicators to assess SAB Biotherapeutics Inc. Equity Warrant potentialJuly 2025 Gainers & Precise Buy Zone Identification - Newser
Combining price and volume data for SAB Biotherapeutics Inc.Bear Alert & AI Powered Buy and Sell Recommendations - Newser
SAB Biotherapeutics Inc. stock trend outlook and recovery path2025 Top Decliners & Verified Stock Trade Ideas - Newser
How to read the order book for SAB Biotherapeutics Inc.2025 Historical Comparison & Growth Oriented Trade Recommendations - Newser
Momentum divergence signals in SAB Biotherapeutics Inc. Equity Warrant chart2025 Support & Resistance & Free Technical Pattern Based Buy Signals - Newser
How hedge fund analytics apply to SAB Biotherapeutics Inc. stockMarket Trend Report & Verified Stock Trade Ideas - Newser
How to build a dashboard for SAB Biotherapeutics Inc. Equity Warrant stockGDP Growth & Reliable Momentum Entry Alerts - Newser
Will SAB Biotherapeutics Inc. outperform the marketJuly 2025 Big Picture & Risk Controlled Daily Plans - Newser
Chart based analysis of SAB Biotherapeutics Inc. Equity Warrant trendsDay Trade & Capital Protection Trade Alerts - Newser
Visualizing SAB Biotherapeutics Inc. stock with heatmaps2025 Year in Review & Daily Profit Maximizing Tips - Newser
Developing predictive dashboards with SAB Biotherapeutics Inc. Equity Warrant dataCEO Change & Low Risk High Win Rate Picks - Newser
Statistical indicators supporting SAB Biotherapeutics Inc. Equity Warrant’s strength2025 Year in Review & Smart Allocation Stock Reports - Newser
Best data tools to analyze SAB Biotherapeutics Inc. stockWeekly Market Report & Low Volatility Stock Recommendations - Newser
Analyzing recovery setups for SAB Biotherapeutics Inc. Equity Warrant investors - Newser
Using fundamentals and technicals on SAB Biotherapeutics Inc.2025 Earnings Surprises & Reliable Entry Point Trade Alerts - Newser
Analyzing drawdowns of SAB Biotherapeutics Inc. Equity Warrant with statistical toolsQuarterly Portfolio Review & Daily Momentum Trading Reports - Newser
Has SAB Biotherapeutics Inc. formed a bullish divergenceQuarterly Trade Summary & Long-Term Capital Growth Strategies - Newser
Can SAB Biotherapeutics Inc. Equity Warrant hit a new high this monthTrade Signal Summary & Intraday High Probability Alerts - Newser
What to expect from SAB Biotherapeutics Inc. Equity Warrant in the next 30 days2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
Analyzing drawdowns of SAB Biotherapeutics Inc. with statistical toolsQuarterly Trade Report & Low Volatility Stock Recommendations - Newser
SAB Biotherapeutics Inc. Equity Warrant stock volume spike explained2025 Support & Resistance & Long-Term Safe Return Strategies - Newser
Predicting SAB Biotherapeutics Inc. trend using moving averagesWeekly Gains Report & Risk Controlled Stock Pick Alerts - Newser
How to track smart money flows in SAB Biotherapeutics Inc.Weekly Trade Recap & Fast Entry High Yield Tips - Newser
Will SAB Biotherapeutics Inc. stock go up soonBuy Signal & Daily Chart Pattern Signals - Newser
Will SAB Biotherapeutics Inc. Equity Warrant rebound enough to break evenWeekly Investment Report & Verified Short-Term Trading Plans - Newser
Technical analysis overview for SAB Biotherapeutics Inc. stockAnalyst Downgrade & Risk Managed Trade Strategies - Newser
Chart overlay techniques for tracking SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Levels & Precise Buy Zone Identification - Newser
Sab Biotherapeutics Inc Stock (SABS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):